Value analysis has historically focused on evaluating products based on cost and efficacy. But as we move to a value-based healthcare system, we must consider other socio-economic and environmental factors.

This session will explore the concept of a clinically and socially integrated supply chain, where products are assessed on an expanded array of factors that impact population health and the achievement of a health system’s strategic objectives.

Conway will present a methodology that organizations can use to score products based on a range of factors, including their role in reducing health disparities and fighting climate change.